RZRogelio Zapata-Arenas

Rogelio Zapata-Arenas

*This is an algorithmically generated author record based on publicly available information.

Rogelio Zapata-Arenas has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AIDS-related disseminated Kaposi Sarcoma: a case report

    by Samanta Ruiz, Juan José Díaz-Vintimilla, Maximiliano Trevilla-Viveros, Rogelio Zapata-Arenas, Tamara Monserrat Mejia-Alcantara

    Kaposi sarcoma (KS) is the most common malignant tumor in HIV-infected individuals. Although its most common form consists of skin and mucosal lesions, it can also present itself in a disseminated way affecting the gastrointestinal tract, lungs and eye structures. We present the case of a 27-year-old male patient with HIV infection and disseminated Kaposi sarcoma. Disseminated KS is an uncommon form of the disease. Therefore, it is important to take this into account, particularly in HIV-infected individuals with characteristic cutaneous lesions.

  • Open Access

    Subacute transverse myelitis as a clinical presentation of neurobrucellosis

    by Juan José Díaz-Vintimilla, Luis Adrián Rosales Hernández, Rogelio Zapata-Arenas, Sokani Sánchez-Montes, Ingeborg Becker

    Brucella melitensis is the main cause of human brucellosis worldwide and is considered the most virulent and neurotropic species. In Mexico, this species is considered endemic, being reported since the first decade of the 20th century. Here we present a case of subacute transverse myelitis with the isolation and identification of B. melitensis as the causative agent of Neurobrucellosis in a female patient from the coastal state of Guerrero, Mexico.


  • Open Access

    The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19)

    by Salma A. Rizo-Téllez, Lucia A. Méndez-García, Cruz Flores-Rebollo, Fernando Alba-Flores, Raúl Alcántara-Suárez, Aarón N. Manjarrez-Reyna, Neyla Baltazar-López, Verónica A. Hernández-Guzmán, José I. León-Pedroza, Rogelio Zapata-Arenas, et al.

    There is a deep need for mortality predictors that allow clinicians to quickly triage patients with severe coronavirus disease 2019 (Covid-19) into intensive care units at the time of hospital admission. Thus, we examined the efficacy of the lymphocyte-to-neutrophil ratio (LNR) and neutrophil-to-monocyte ratio (NMR) as predictors of in-hospital death at admission in patients with severe Covid-19. A total of 54 Mexican adult patients with Covid-19 that met hospitalization criteria were retrospectively enrolled, followed-up daily until hospital discharge or death, and then assigned to survival or non-survival groups. Clinical, demographic, and laboratory parameters were recorded at admission. A total of 20 patients with severe Covid-19 died, and 75% of them were men older than 62.90 ± 14.18 years on average. Type 2 diabetes, hypertension, and coronary heart disease were more prevalent in non-survivors. As compared to survivors, LNR was significantly fourfold decreased while NMR was twofold increased. LNR ≤ 0.088 predicted in-hospital mortality with a sensitivity of 85.00% and a specificity of 74.19%. NMR ≥ 17.75 was a better independent risk factor for mortality with a sensitivity of 89.47% and a specificity of 80.00%. This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19.